Try our Advanced Search for more refined results

PERRI v. NOVARTIS PHARMACEUTICALS CORPORATION et al

  1. April 16, 2020

    Novartis Must Face Retaliation Suit Over Kickback Scheme

    Novartis Pharmaceuticals Corp. lost its bid to toss a former employee's revised False Claims Act suit after a New Jersey federal judge said Thursday that the ex-worker's alleged conversation with his boss supported claims he was fired for objecting to a purported kickback scheme involving Express Scripts Inc.

  2. October 21, 2019

    Novartis Hit With Retaliation Suit Over Kickback Scheme

    A former Novartis Pharmaceuticals Corp. employee on Monday launched a revised suit in New Jersey federal court alleging he was fired for objecting to a purported kickback scheme in which the company provided commercial discounts on multiple sclerosis drug Gilenya to Express Scripts Inc. in exchange for Medicare Part D business.

  3. February 22, 2019

    Novartis, Express Scripts Beat Kickback Suit Over Discounts

    Novartis Pharmaceuticals Corp. and Express Scripts Inc. have escaped a suit alleging they engaged in a kickback scheme after a New Jersey federal judge found that a former Novartis employee failed to back up his claims that the company illegally provided commercial discounts on multiple sclerosis drug Gilenya in exchange for Medicare Part D business.

  4. September 19, 2018

    Novartis Warping Kickback Standard In FCA Case, DOJ Says

    Novartis Pharmaceuticals Corp. has flatly "misstated the law" in its bid to escape a whistleblower's False Claims Act suit alleging illicit kickbacks aimed at boosting Medicare Part D business, the U.S. Department of Justice told a New Jersey federal court Tuesday.